Recognition of asthma in adolescents and young adults: Which objective measure is best?

Journal of Asthma

Volumn 42, Issue 7, 2005, Pages 549-554

  Ulrik, Charlotte Suppli ^a,d   Postma, Dirkje S ^b   Backer, Vibeke ^c  

^a HVIDOVRE HOSPITAL   (Denmark)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c BISPEBJERG HOSPITAL   (Denmark)

^d NONE   (Denmark)

Author keywords

Airway responsiveness; Asthma; Epidemiology; Peak flow variability; Reversibility

Indexed keywords

CORTICOSTEROID;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; ASTHMA; BRONCHODILATATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; EOSINOPHIL COUNT; FEMALE; HUMAN; INTERVIEW; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PREVALENCE; PRICK TEST; QUESTIONNAIRE; SELF REPORT; SMOKING;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; ANTI-ASTHMATIC AGENTS; ANTIGENS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHODILATOR AGENTS; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; FORCED EXPIRATORY VOLUME; HISTAMINE; HUMANS; INTRADERMAL TESTS; LUNG VOLUME MEASUREMENTS; MALE; PEAK EXPIRATORY FLOW RATE; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SMOKING; VITAL CAPACITY;

EID: 28844491868     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900500215715     Document Type: Article

References (38)

1. Kanner RE. The relationship between airways responsiveness and chronic airflow obstruction. Chest 1984; 86:54-57.
2. National Heart Lung, and Blood Institute, World Health Organization. Global Initiative for Asthma: A Global Strategy for Asthma Management and Prevention. Bethesda, MD: National Institute of Health, 1995.
3. Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987; 70:171-179.
4. Britton J, Lewis S. Objective measures and the diagnosis of asthma. BMJ 1998; 317:227-228.
5. Backer V. Bronchial hyperresponsiveness in children and adolescents. In: Thesis. København: Lægeforeningens Forlag, 1995:3-18.
6. Ulrik CS. Comparison of stayers, dropouts and newcomers in a longitudinal population study of asthma and bronchial hyperresponsiveness: introduction of bias? J Asthma 1995; 32:295-300.
7. Ulrik CS, Backer V. Increased bronchial responsiveness to exercise as a risk factor for symptomatic asthma: findings from a longitudinal population study of children and adolescents. Eur Respir J 1996; 9:1696-1700.
8. Ferris BG Sr, American Thoracic Society Executive Committee. Standardization projects. Am Rev Respir Dis 1978; 118:1-20.
9. United States Department of Health, Education and Welfare. Proceedings. First NHLBI Epidemiology Workshop. Washington, DC: United States Government Printing Office, 1971.
10. Hopp RJ, Bewtra AK, Nair NM, Townley RG. Specificity and sensitivity of methacholine inhalation challenge in normal and asthmatic children. J Allergy Clin Immunol 1984; 74:154-158.
11. Hopp RJ, Townley RG, Biwen RE, Bewtra AK, Nair NM. The presence of airway reactivity before development of asthma. Am Rev Respir Dis 1990; 141:2-8.
12. Quanjer PH, Borsboom GJ, Brunekreef B, Zach M, Forche G, Cotes JE, Sanchis J, Paoletti P. Spirometric reference values for white European children and adolescents: polgar revisited. Pediatr Pulmonol 1995; 19:135-142.
13. Quanjer PH, Tammeling GJ. Summary of recommendations. Standardized lung function testing, Report Working Party, European Community for Coal and Steel. Bull Eur Physiopathol Respir 1983; 19(suppl 5):7-10.
14. Nysom K, Ulrik CS, Hesse B, Dirksen A. Published models and local data can brigde the gap between reference values of lung function for children and adults. Eur Respir J 1997; 10:1591-1598.
15. Cockcroft DW, Killian KN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977; 7:235-243.
16. Ulrik CS, Backer V. Markers for impaired growth of pulmonary function in children and adolescents. Am J Respir Crit Care Med 1999; 160:40-44.
17. Juniper EF, Cockcroft DW, Hargreave FE. Histamine and Methacholine Tests: Tidal Breathing Method, Laboratory Procedure and Standardisation. Canadian Thoracic Society, 1991:28.
18. O'Connor G, Sparrow D, Taylor D, Weis ST. Analysis of dose-response curves to methacholine. An approach suitable for population studies. Am Rev Respir Dis 1987; 136:1412-1417.
19. Reddel H, Jenkins C, Woolcock AJ. Diurnal variability - time to change asthma guidelines? BMJ 1999; 319:45-47.
20. Gerritsen J, Koeter GH, Akkerboom HJ, Knol K. Recovery of FEV1 after histamine challenge in asthmatic children. Clin Allergy 1987; 17:119-126.
21. Dreborg S. The Skin Prick Test. Methodological Studies and Clinical Applications. Medical Dissertations No. 239, Linkoping University, 1987:1-148.
22. Uhrband H. Tælling af cirkulerende eosinophile celler i tællekammer (in Danish, summary in English). Ugeskr Laeger 1952; 114:385-393.
23. Felarca AB, Lowell FC. The total eosinophil count in a nonatopic population. J Allergy 1967; 40:16-20.
24. Lyut DK, Burton PR, Simpson J. Epidemiologic study of wheeze, doctor diagnosed asthma, and cough in preschool children in Leicestershire. Br Med J 1993; 306:1386-1390.
25. Peat JK, Toelle BG, Marks GB, Mellis CM. Continuing the debate about measuring asthma in population studies. Thorax 2001; 56:406-411.
26. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16:802-807.
27. Jogi R, Janson C, Bjornsson E, Boman G, Bjorksten B. Atopic and allergic disorders among adults in Tartu, Estonia, compared with Uppsala, Sweden. Clin Exp Allergy 1998; 28:1072-1080.
28. Rona RJ, Chinn S, Burney PGJ. Trends in prevalence of asthma in Scottish and English primary school children, 1982-92. Thorax 1995; 50:992-993.
29. Peat JK, Tovey ER, Toelle BG, Woolcock AJ. House-dust mite allergens: a major risk factor for childhood asthma in Australia. Am J Respir Crit Care Med 1996; 153:141-146.
30. Remes ST, Pekkanen J, Remes K, Salonen RO, Korppi M. In search of childhood asthma: questionnaire, tests of bronchial responsiveness, and clinical evaluation. Thorax 2002; 57:120-126.
31. Magnus P, Jaakkola JJ. Secular trend in the occurrence of asthma among children and young adults: critical appraisal of repeated cross sectional surveys. Br Med J 1997; 314:1795-1799.
32. Peat JK, Toelle BG, Mellis CM. Problems and possibilities in understanding the natural history of asthma. J Allergy Clin Immunol 2000; 106:S144-S152.
33. Ulrik CS, Backer V, Hesse B, Dirksen A. Risk factors for the development of asthma in children and adolescents: findings from a longitudinal population study. Respir Med 1996; 90:623-630.
34. Kerstjens HA, Brand PL, de Jong PM, Koeter GH, Postma DS. Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. The Dutch CNSLD Study Group. Thorax 1994; 49:1109-1115.
35. Brand PL, Duiverman EJ, Waalkens HJ, van Essen-Zandvliet EE, Kerrebijn KF. Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during longterm treatment with inhaled corticosteroids. Dutch CNSLD Group. Thorax 1999; 54:103-107.
36. Kamps AWA, Roorda RJ, Brand PLP. Peak flow diaries in childhood asthma are unreliable. Thorax 2001; 56:180-182.
37. Hyland ME, Kenyon CAP, Allen R, Howarth P. Diary keeping in asthma: comparison of written and electronic methods. Br Med J 1993; 306:487-489.
38. Lebowitz MD, Krzyzanowski M, Quackenboss JJ, O'Rourke MK. Diurnal variation of PEF and its use in epidemiological studies. Eur Respir J 1997; 10(suppl 24):49s-56s.